Verano Holdings (VRNO) Cash from Operations (2021 - 2026)
Verano Holdings' (VRNO) quarterly Cash from Operations came in at 18587000.0 in Q1 2026, up 940.71% year-on-year from 1786000.0 in Q1 2025, and up 34.54% on a QoQ basis from 13815000.0 in Q4 2025.
Verano Holdings (VRNO) Cash from Operations (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Cash from Operations data on file, last reported at 18587000.0 in Q1 2026.
- On a quarterly basis, Cash from Operations rose 940.71% year-over-year to 18587000.0 in Q1 2026; TTM through Mar 2026 was 69656000.0, a 16.02% decrease from a year earlier, with the FY2025 full-year figure at 52855000.0, down 52.89% from the prior year.
- Cash from Operations for Q1 2026 stood at 18587000.0, up from 13815000.0 in the prior quarter.
- Over the last five years, Cash from Operations for VRNO reached as high as 43501000.0 in Q4 2024 and fell as low as 1786000.0 in Q1 2025.
- Historically, Cash from Operations has averaged 22805529.41 across 5 years, with a median of 23878000.0 in 2023.
- Across the five-year window, Cash from Operations plunged 94.25% in 2025 and soared 940.71% in 2026, its largest moves.
- Year by year, Cash from Operations stood at 29036000.0 in 2022, then advanced by 11.41% to 32349000.0 in 2023, then jumped by 34.47% to 43501000.0 in 2024, then plunged by 68.24% to 13815000.0 in 2025, then jumped by 34.54% to 18587000.0 in 2026.
- Per Business Quant data, the three most recent Cash from Operations figures were 18587000.0 in Q1 2026, 13815000.0 in Q4 2025, and 26354000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -40.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 401.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 463.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 388.30 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 145.80 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.00 Mn |
| 10 | Verano Holdings | 2.02 Bn | 1.94 Bn | 98.98 Mn | 18.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.59 Mn |
| Mar 31, 2026 | 18.59 Mn |
| Dec 31, 2025 | 13.82 Mn |
| Dec 31, 2025 | 13.82 Mn |
| Sep 30, 2025 | 26.35 Mn |
| Sep 30, 2025 | 26.35 Mn |
| Jun 30, 2025 | 10.90 Mn |
| Jun 30, 2025 | 10.90 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 43.50 Mn |
| Dec 31, 2024 | 43.50 Mn |
| Sep 30, 2024 | 29.73 Mn |
| Sep 30, 2024 | 29.73 Mn |
| Jun 30, 2024 | 7.92 Mn |
| Jun 30, 2024 | 7.92 Mn |
| Mar 31, 2024 | 31.04 Mn |
| Mar 31, 2024 | 31.04 Mn |
| Dec 31, 2023 | 32.35 Mn |
| Dec 31, 2023 | 32.35 Mn |